Risk Factors of Capecitabine-Induced Hand-Foot Syndrome: A Single-Institution, Retrospective Study.

Kanbayashi, Yuko; Taguchi, Tetsuya; Ishikawa, Takeshi; Otsuji, Eigo; Takayama, Koichi

Kanbayashi, Yuko; Taguchi, Tetsuya; Ishikawa, Takeshi; Otsuji, Eigo; Takayama, Koichi.

Affiliation

Kanbayashi Y; Department of Outpatient Oncology Unit, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Taguchi T; Department of Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Ishikawa T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Otsuji E; Department of Endocrine and Breast Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takayama K; Department of Outpatient Oncology Unit, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Oncology ; 101(7): 407-414, 2023.

Article de En | MEDLINE | ID: mdl-37075722

Sujet(s)
Mots clés

Albumin; Body surface area; Capecitabine; Hand-foot syndrome; Renin-angiotensin system inhibitor

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Qualité de vie / Syndrome mains-pieds Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Humans Langue: En Journal: Oncology Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google